These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 33743481)

  • 1. Uptake of hysterectomy and bilateral salpingo-oophorectomy in carriers of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report.
    Seppälä TT; Dominguez-Valentin M; Crosbie EJ; Engel C; Aretz S; Macrae F; Winship I; Capella G; Thomas H; Hovig E; Nielsen M; Sijmons RH; Bertario L; Bonanni B; Tibiletti MG; Cavestro GM; Mints M; Gluck N; Katz L; Heinimann K; Vaccaro CA; Green K; Lalloo F; Hill J; Schmiegel W; Vangala D; Perne C; Strauß HG; Tecklenburg J; Holinski-Feder E; Steinke-Lange V; Mecklin JP; Plazzer JP; Pineda M; Navarro M; Vida JB; Kariv R; Rosner G; Piñero TA; Pavicic W; Kalfayan P; Ten Broeke SW; Jenkins MA; Sunde L; Bernstein I; Burn J; Greenblatt M; de Vos Tot Nederveen Cappel WH; Della Valle A; Lopez-Koestner F; Alvarez K; Büttner R; Görgens H; Morak M; Holzapfel S; Hüneburg R; von Knebel Doeberitz M; Loeffler M; Redler S; Weitz J; Pylvänäinen K; Renkonen-Sinisalo L; Lepistö A; Hopper JL; Win AK; Lindor NM; Gallinger S; Le Marchand L; Newcomb PA; Figueiredo JC; Thibodeau SN; Therkildsen C; Wadt KAW; Mourits MJE; Ketabi Z; Denton OG; Rødland EA; Vasen H; Neffa F; Esperon P; Tjandra D; Möslein G; Rokkones E; Sampson JR; Evans DG; Møller P
    Eur J Cancer; 2021 May; 148():124-133. PubMed ID: 33743481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk-reducing hysterectomy and bilateral salpingo-oophorectomy in female heterozygotes of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report.
    Dominguez-Valentin M; Crosbie EJ; Engel C; Aretz S; Macrae F; Winship I; Capella G; Thomas H; Nakken S; Hovig E; Nielsen M; Sijmons RH; Bertario L; Bonanni B; Tibiletti MG; Cavestro GM; Mints M; Gluck N; Katz L; Heinimann K; Vaccaro CA; Green K; Lalloo F; Hill J; Schmiegel W; Vangala D; Perne C; Strauß HG; Tecklenburg J; Holinski-Feder E; Steinke-Lange V; Mecklin JP; Plazzer JP; Pineda M; Navarro M; Vidal JB; Kariv R; Rosner G; Piñero TA; Gonzalez ML; Kalfayan P; Ryan N; Ten Broeke SW; Jenkins MA; Sunde L; Bernstein I; Burn J; Greenblatt M; de Vos Tot Nederveen Cappel WH; Della Valle A; Lopez-Koestner F; Alvarez K; Büttner R; Görgens H; Morak M; Holzapfel S; Hüneburg R; von Knebel Doeberitz M; Loeffler M; Rahner N; Weitz J; Pylvänäinen K; Renkonen-Sinisalo L; Lepistö A; Auranen A; Hopper JL; Win AK; Haile RW; Lindor NM; Gallinger S; Le Marchand L; Newcomb PA; Figueiredo JC; Thibodeau SN; Therkildsen C; Okkels H; Ketabi Z; Denton OG; Rødland EA; Vasen H; Neffa F; Esperon P; Tjandra D; Möslein G; Sampson JR; Evans DG; Seppälä TT; Møller P
    Genet Med; 2021 Apr; 23(4):705-712. PubMed ID: 33257847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness Analysis of Genotype-Specific Surveillance and Preventive Strategies for Gynecologic Cancers Among Women With Lynch Syndrome.
    Wright JD; Silver ER; Tan SX; Hur C; Kastrinos F
    JAMA Netw Open; 2021 Sep; 4(9):e2123616. PubMed ID: 34499134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk-Reducing Gynecological Surgery in Lynch Syndrome: Results of an International Survey from the Prospective Lynch Syndrome Database.
    Dominguez-Valentin M; Seppälä TT; Engel C; Aretz S; Macrae F; Winship I; Capella G; Thomas H; Hovig E; Nielsen M; Sijmons RH; Bertario L; Bonanni B; Tibiletti MG; Cavestro GM; Mints M; Gluck N; Katz L; Heinimann K; Vaccaro CA; Green K; Lalloo F; Hill J; Schmiegel W; Vangala D; Perne C; Strauß HG; Tecklenburg J; Holinski-Feder E; Steinke-Lange V; Mecklin JP; Plazzer JP; Pineda M; Navarro M; Vidal JB; Kariv R; Rosner G; Piñero TA; Gonzalez ML; Kalfayan P; Sampson JR; Ryan NAJ; Evans DG; Møller P; Crosbie EJ
    J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32708519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer Risks for PMS2-Associated Lynch Syndrome.
    Ten Broeke SW; van der Klift HM; Tops CMJ; Aretz S; Bernstein I; Buchanan DD; de la Chapelle A; Capella G; Clendenning M; Engel C; Gallinger S; Gomez Garcia E; Figueiredo JC; Haile R; Hampel HL; Hopper JL; Hoogerbrugge N; von Knebel Doeberitz M; Le Marchand L; Letteboer TGW; Jenkins MA; Lindblom A; Lindor NM; Mensenkamp AR; Møller P; Newcomb PA; van Os TAM; Pearlman R; Pineda M; Rahner N; Redeker EJW; Olderode-Berends MJW; Rosty C; Schackert HK; Scott R; Senter L; Spruijt L; Steinke-Lange V; Suerink M; Thibodeau S; Vos YJ; Wagner A; Winship I; Hes FJ; Vasen HFA; Wijnen JT; Nielsen M; Win AK
    J Clin Oncol; 2018 Oct; 36(29):2961-2968. PubMed ID: 30161022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Mismatch Repair Mutation With Age at Cancer Onset in Lynch Syndrome: Implications for Stratified Surveillance Strategies.
    Ryan NAJ; Morris J; Green K; Lalloo F; Woodward ER; Hill J; Crosbie EJ; Evans DG
    JAMA Oncol; 2017 Dec; 3(12):1702-1706. PubMed ID: 28772289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome.
    Dillon JL; Gonzalez JL; DeMars L; Bloch KJ; Tafe LJ
    Hum Pathol; 2017 Dec; 70():121-128. PubMed ID: 29107668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality by age, gene and gender in carriers of pathogenic mismatch repair gene variants receiving surveillance for early cancer diagnosis and treatment: a report from the prospective Lynch syndrome database.
    Dominguez-Valentin M; Haupt S; Seppälä TT; Sampson JR; Sunde L; Bernstein I; Jenkins MA; Engel C; Aretz S; Nielsen M; Capella G; Balaguer F; Evans DG; Burn J; Holinski-Feder E; Bertario L; Bonanni B; Lindblom A; Levi Z; Macrae F; Winship I; Plazzer JP; Sijmons R; Laghi L; Della Valle A; Heinimann K; Dębniak T; Fruscio R; Lopez-Koestner F; Alvarez-Valenzuela K; Katz LH; Laish I; Vainer E; Vaccaro C; Carraro DM; Monahan K; Half E; Stakelum A; Winter D; Kennelly R; Gluck N; Sheth H; Abu-Freha N; Greenblatt M; Rossi BM; Bohorquez M; Cavestro GM; Lino-Silva LS; Horisberger K; Tibiletti MG; Nascimento ID; Thomas H; Rossi NT; Apolinário da Silva L; Zaránd A; Ruiz-Bañobre J; Heuveline V; Mecklin JP; Pylvänäinen K; Renkonen-Sinisalo L; Lepistö A; Peltomäki P; Therkildsen C; Madsen MG; Burgdorf SK; Hopper JL; Win AK; Haile RW; Lindor N; Gallinger S; Le Marchand L; Newcomb PA; Figueiredo J; Buchanan DD; Thibodeau SN; von Knebel Doeberitz M; Loeffler M; Rahner N; Schröck E; Steinke-Lange V; Schmiegel W; Vangala D; Perne C; Hüneburg R; Redler S; Büttner R; Weitz J; Pineda M; Duenas N; Vidal JB; Moreira L; Sánchez A; Hovig E; Nakken S; Green K; Lalloo F; Hill J; Crosbie E; Mints M; Goldberg Y; Tjandra D; Ten Broeke SW; Kariv R; Rosner G; Advani SH; Thomas L; Shah P; Shah M; Neffa F; Esperon P; Pavicic W; Torrezan GT; Bassaneze T; Martin CA; Moslein G; Moller P
    EClinicalMedicine; 2023 Apr; 58():101909. PubMed ID: 37181409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological features of 50 mismatch repair (MMR)-deficient endometrial carcinomas, tested by immunohistochemistry: A single institutional feasibility study, India.
    Rekhi B; Menon S; Deodhar KK; Ghosh J; Chopra S; Maheshwari A
    Ann Diagn Pathol; 2020 Aug; 47():151558. PubMed ID: 32619922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary peritoneal cancer after bilateral salpingo-oophorectomy in two patients with Lynch syndrome.
    Schmeler KM; Daniels MS; Soliman PT; Broaddus RR; Deavers MT; Vu TM; Chang GJ; Lu KH
    Obstet Gynecol; 2010 Feb; 115(2 Pt 2):432-434. PubMed ID: 20093870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancer.
    Mills AM; Liou S; Ford JM; Berek JS; Pai RK; Longacre TA
    Am J Surg Pathol; 2014 Nov; 38(11):1501-9. PubMed ID: 25229768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of care and outcomes of risk reducing surgery in women with pathogenic variants in non-BRCA and Lynch syndrome ovarian cancer susceptibility genes.
    Schwartz ZP; Li AJ; Walsh CS; Rimel BJ; Alvarado MM; Lentz SE; Cass I
    Gynecol Oncol; 2023 Jun; 173():1-7. PubMed ID: 37030072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lynch Syndrome in Thai Endometrial Cancer Patients.
    Manchana T; Ariyasriwatana C; Triratanachat S; Phowthongkum P
    Asian Pac J Cancer Prev; 2021 May; 22(5):1477-1483. PubMed ID: 34048176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of Pathogenic Variants in MLH1, MSH2, and MSH6 With Risk of Colorectal Adenomas and Tumors and With Somatic Mutations in Patients With Lynch Syndrome.
    Engel C; Ahadova A; Seppälä TT; Aretz S; Bigirwamungu-Bargeman M; Bläker H; Bucksch K; Büttner R; de Vos Tot Nederveen Cappel WT; Endris V; Holinski-Feder E; Holzapfel S; Hüneburg R; Jacobs MAJM; Koornstra JJ; Langers AM; Lepistö A; Morak M; Möslein G; Peltomäki P; Pylvänäinen K; Rahner N; Renkonen-Sinisalo L; Schulmann K; Steinke-Lange V; Stenzinger A; Strassburg CP; van de Meeberg PC; van Kouwen M; van Leerdam M; Vangala DB; Vecht J; Verhulst ML; von Knebel Doeberitz M; Weitz J; Zachariae S; Loeffler M; Mecklin JP; Kloor M; Vasen HF; ;
    Gastroenterology; 2020 Apr; 158(5):1326-1333. PubMed ID: 31926173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancy.
    Najdawi F; Crook A; Maidens J; McEvoy C; Fellowes A; Pickett J; Ho M; Nevell D; McIlroy K; Sheen A; Sioson L; Ahadi M; Turchini J; Clarkson A; Hogg R; Valmadre S; Gard G; Dooley SJ; Scott RJ; Fox SB; Field M; Gill AJ
    Pathology; 2017 Aug; 49(5):457-464. PubMed ID: 28669579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic Gynecologic Surgery at Time of Colectomy Benefits Women with Lynch Syndrome and Colon Cancer: A Markov Cost-Effectiveness Analysis.
    Ofshteyn A; Jiang B; Bingmer K; Nakayama JM; Gallego C; Giglia M; Stein SL; Steinhagen E
    Dis Colon Rectum; 2020 Oct; 63(10):1393-1402. PubMed ID: 32969882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome.
    Rabban JT; Calkins SM; Karnezis AN; Grenert JP; Blanco A; Crawford B; Chen LM
    Am J Surg Pathol; 2014 Jun; 38(6):793-800. PubMed ID: 24503759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of implementation of risk management guidelines for carriers of pathogenic variants in mismatch repair genes: a nationwide audit of familial cancer clinics.
    Meiser B; Kaur R; Kirk J; Morrow A; Peate M; Wong WKT; McPike E; Cops E; Dowson C; Austin R; Fine M; Thrupp L; Ward R; Macrae F; Hiller JE; Trainer AH; Mitchell G;
    Fam Cancer; 2020 Oct; 19(4):337-346. PubMed ID: 32385704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population.
    Lagerstedt-Robinson K; Rohlin A; Aravidis C; Melin B; Nordling M; Stenmark-Askmalm M; Lindblom A; Nilbert M
    Oncol Rep; 2016 Nov; 36(5):2823-2835. PubMed ID: 27601186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A model-based assessment of the cost-utility of strategies to identify Lynch syndrome in early-onset colorectal cancer patients.
    Snowsill T; Huxley N; Hoyle M; Jones-Hughes T; Coelho H; Cooper C; Frayling I; Hyde C
    BMC Cancer; 2015 Apr; 15():313. PubMed ID: 25910169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.